Carregant...
Cetuximab Immunoliposomes enhance Delivery of 5-FU to Skin Squamous Carcinoma Cells
Topical chemotherapy of skin cancers is a promising strategy for reduction of side effects and for improvement of patient compliance. The combination of the chemotherapeutic 5-fluouracil (5-FU) and the anti-EGFR antibody cetuximab is a strategy to inhibit tumor growth. Their skin penetration, howeve...
Guardat en:
| Publicat a: | Anticancer Agents Med Chem |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5124425/ https://ncbi.nlm.nih.gov/pubmed/27225449 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|